OLIDIA referencias disponibles en ALLPARA para uso profesional, de origen directo y certificadas en cada envío.
Olidia 240
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.
Principales ventajas de Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indicaciones y uso profesional
Indicaciones principales
- Moderate to severe nasolabial folds
Uso profesional
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Zonas de tratamiento
- Moderate to severe nasolabial folds.
Perfil del paciente
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
Cómo funciona Olidia 240
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Por qué comprar en Allpara
Allpara ofrece productos OLIDIA originales y verificados de proveedores seleccionados, con trazabilidad completa de lotes y asesoramiento experto. Atendemos a clínicas y profesionales de la estética con productos con certificado CE, entrega rápida en toda la UE desde nuestro almacén en la UE y precios profesionales competitivos. Nuestra prioridad es la seguridad, la satisfacción y los resultados de sus pacientes, con un servicio posventa dedicado para su tranquilidad.
Preguntas frecuentes
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.
Más productos de PRP Life Science
Alternativas para la clínica
Retome donde lo dejó
Olidia 240
Olidia 240 is an injectable, sterile absorbable poly-L-lactic acid (PLLA) dermal filler by PRP Life Science Co., Ltd. in South Korea, created for the temporary improvement of moderate to severe nasolabial folds. It is suitable for professionals who administer it by injection into the deep dermis or the subcutaneous (subdermal) layer. The formulation combines PLLA with carboxymethylcellulose (CMC) and mannitol at a dose of 243.4 mg per vial and is intended for professional use.
Principales ventajas de Olidia 240
- Improves moderate to severe nasolabial folds
- PLLA-based formulation designed for a gradual tissue response after injection
- For professional injection into the deep dermis or subdermal layer
- CE-marked medical device (CE 1434)
Indicaciones y uso profesional
Indicaciones principales
- Moderate to severe nasolabial folds
Uso profesional
For professional use only, by trained physicians. Olidia 240 is administered by injection into the deep dermis or subdermal layer to temporarily improve moderate to severe nasolabial folds. Ensure the product is sterile before use and check the expiration date on the product label. Explain the indications, contraindications, and potential side effects to the patient prior to treatment. Avoid areas where vascular occlusion may occur; injection into blood vessels may cause serious effects including blindness, so avoid areas of thin skin and high vascularity such as the glabella and periorbital areas. Do not inject into the vermilion of the lips; safety and efficacy for lip augmentation are not established.
Zonas de tratamiento
- Moderate to severe nasolabial folds.
Perfil del paciente
Do not use until any infection or inflammation at or near the injection site is resolved. Do not use in patients hypersensitive to the product or its components. Safety has not been established in patients susceptible to keloids, hyperpigmentation, or hypertrophic scarring. In patients with a history of herpetic eruption, injection may trigger recurrence.
Cómo funciona Olidia 240
Olidia 240 works through poly-L-lactic acid (PLLA) combined with carboxymethylcellulose and mannitol. Injected into the deep dermis or subdermal layer, the PLLA stimulates a gradual tissue response to temporarily improve moderate to severe nasolabial folds.
Por qué comprar en Allpara
Allpara ofrece productos OLIDIA originales y verificados, con trazabilidad completa de lotes, stock con certificado CE, entrega rápida en toda la UE y servicio posventa experto.
Preguntas frecuentes
What is Olidia 240 used for?
Olidia 240 is used to temporarily improve moderate to severe nasolabial folds.
What is in the Olidia 240 formula?
Olidia 240 contains poly-L-lactic acid (PLLA) with carboxymethylcellulose (CMC) and mannitol, at a dose of 243.4 mg per vial.
Where is Olidia 240 injected?
Olidia 240 is injected into the deep dermis or subdermal layer.